SCHEMBL17757678

SCHEMBL17757678

CN1CCC2(CC1)Nc1cc(Cl)c(Cl)cc1N=C2NCc1cnnc(N(C)C)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17757144 0.85 CCNT1 (0.33) —
SCHEMBL21982520 0.84 — —
SCHEMBL17757137 0.83 — —
SCHEMBL17757502 0.81 CCNT1 (0.38) —
SCHEMBL17757659 0.80 CCNT1 (0.40) —
SCHEMBL17757674 0.80 HRH4 (0.31) —
SCHEMBL17757139 0.79 CDK2 (0.41) —
SCHEMBL17757143 0.79 MAPK7 (0.34) —
SCHEMBL21982511 0.78 HRH4 (0.42) —
SCHEMBL17757676 0.78 KCNK2 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10647687-B2 Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death HELMHOLTZ ZENTRUM MÜNCHEN DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH) (DE) 2020-05-12 — — US disclosed
WO-2016075137-A1 SPIROPYRAZINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2016-05-19 — — WO disclosed
Send feedback